U.S. President Donald Trumphas signed an executive order demanding a speedy reclassification of marijuana that would ease ...
Huxley Medical, Inc. announced the SANSA® home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...
High blood pressure (hypertension) can be caused by a variety of factors, including your lifestyle, medical conditions, ...
LUMRYZ is only currently approved for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy, and Avadel does not market, promote or offer patient support services ...
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study ...
Sulthiame reduced breathing interruptions in sleep apnea patients, pointing toward a viable drug treatment. A European ...
Medical Device Network on MSN
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
The KPAP sleep therapy platform is developed to offer an adaptive and patient-focused alternative to traditional CPAP therapy ...
People living with holiday heart syndrome are at a higher risk of life-threatening arrhythmias, development of persistent and ...
Obstructive sleep apnea (OSA) is a common sleep disorder in the U.S. affecting tens of millions, with estimates ranging from 25 to more than 80 million adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback